🚀 This week Lifebit is headed to Reading, UK, for the OpenEHR conference! Over the next two days, we will be joining the global heath tech community to discuss the latest innovations and the future of open source health data. With talks and discussion sessions from leaders in health tech and data, we’re excited to collaborate on advances in health data interoperability. At Lifebit, we believe that open standards, like OpenEHR, play a crucial role in fostering a connected ecosystem where data is accessed securely across platforms to empower research whilst ensuring privacy of sensitive biomedical data. If you're attending, look out for Lifebit Product Team Sangram Keshari Sahu and Millahat A. to explore how Lifebit's solutions are supporting global health initiatives with cutting-edge technology. Looking forward to the insights and ideas this conference will bring! 🌐✨ #OpenEHR #HealthData #Interoperability #HealthTech #Lifebit
Lifebit
Biotechnology Research
London, England 27,427 followers
Revolutionising genomics & bioinformatics: unified research over distributed big data powered by AI.
About us
At Lifebit, we're pushing forward the frontiers of health and knowledge by democratising access to omics data. We enable all researchers, whether novice or advanced, to run complex analyses and generate meaningful insights fast. Lifebit CloudOS is the world’s first federated genomics platform for unified and secure research over distributed big data - wherever data resides. From top tier pharmaceutical organisations to global research institutes to genetics companies and more, Lifebit CloudOS leads the way with our best-in-class UX/UI, seamless integration to open-source tools, marketplace of proprietary ones, powerful cohort browser, and advanced AI functionality. At Lifebit, we are open source pioneers, innovators redefining our industry. Our driving mission - to revolutionise bioinformatics and biomedical data analysis forever. We are growing fast and looking for more superstars to join our team.
- Website
-
https://lifebit.ai
External link for Lifebit
- Industry
- Biotechnology Research
- Company size
- 51-200 employees
- Headquarters
- London, England
- Type
- Privately Held
- Founded
- 2017
- Specialties
- Software, Data Analysis, Genomics, High Performance Computing (HPC), Cloud Computing, Machine Learning, Bioinformatics, BigData, AI, Biobank, Pharmaceutical, Precision Medicine, and Drug Discovery
Products
Locations
-
Primary
9 Appold Street
London, England EC2A 2AP, GB
Employees at Lifebit
Updates
-
That’s a wrap! What an amazing two days at #BiotechXEurope! 🎉 It was fantastic to meet so many people who are interested in secure data access and analysis to power research and innovation. We had great conversations on advancing precision medicine and heard about some truly ambitious strategies that are shaping the future of healthcare. Huge thanks to the organisers Terrapinn for all their hard work in running a brilliant event, to expomobilia for our fantastic booth, and to Wassermann & Company AG & our barista Stanislav for keeping us fuelled with freshly brewed coffee! ☕ And, of course, a big shoutout to our wonderful Lifebit team—Dr. Maria C. Dunford, Thorben Seeger, Christina Chatzipantsiou, Michael Lawton, Roubini Tsakri, and Hamzah Syed—for making it all happen. #Genomics #PrecisionMedicine #DigitalHealth #SecureDataAccess #Pharma #Healthcare #Lifebit #BiotechX
-
Good morning from Basel! It's day 2 at #BiotechXEurope where things are starting to warm up and we’re excited for another busy day 🌟 Yesterday, we had some fantastic conversations with colleagues from pharma, healthcare and biotech, discussing the latest innovations in precision medicine. A big highlight was our CEO, Dr. Maria C. Dunford, delivering a powerful talk on the challenges for pharma, and hearing from Raghib Ali OBE of Our Future Health UK at the Population Genomics stage. We’re so grateful to everyone who joined us for these discussions. If you’re around today, stop by Booth 736 for a freshly brewed coffee from our barista bar ☕ We’d love to chat about how Lifebit help solve your data challenges for genomics and biomedical research. #Pharma #Healthcare #Biotech #PopulationGenomics #DigitalHealth #SecureData #Networking #BiotechX
-
It’s getting busy here in Basel at #BiotechXEurope. Don’t miss the Population Genomics track this afternoon at 14:25 (CEST), chaired by our very own Thorben Seeger, featuring : ⭐ Lifebit CEO, Dr. Maria C. Dunford discussing the challenges of population genomics for pharma ⭐ Raghib Ali OBE, CEO and Chief Medical Officer of Our Future Health UK Stay tuned for updates 🧬💡 #PopulationGenomics #Genomics #Healthcare #Pharma #BiotechX #Innovation #DigitalHealth #SecureDataAccess #BioTechXEU #Biotechnology #PopulationGenomics #Lifebit
-
We’re ready to go at Booth 736 at #BiotechXEurope! ☕ Our coffee bar is set up, and we’ve got freshly brewed barista coffee waiting for you. Come by, grab a cup, and chat with the Lifebit team about how our Platform and Global Data Network are driving secure data access and transforming global genomics and biomedical research. #BiotechX #Genomics #DigitalHealth #BiomedicalResearch #SecureDataAccess #Networking #CoffeeTime
-
⏳ Just one day to go until #BiotechXEurope! Don’t miss Team Lifebit at Stand 736, where our experts will showcase how our platform and Global Data Network are driving secure data access and transforming global genomics and biomedical research. 🔍 Join us tomorrow at the Population Genomics Track chaired by Thorben Seeger, featuring a keynote by our CEO Dr. Maria C. Dunford on population genomics challenges for pharma, and insights from Raghib Ali at Our Future Health. We’re ready for great conversations and to drive forward innovation to improve population health! Stay tuned for more updates. 🧬💡 Thorben Seeger, Roubini Tsakri, Michael Lawton, Karl Quinn, Hamzah Syed, Christina Chatzipantsiou #PopulationGenomics #Genomics #Healthcare #Pharma #BiotechX #Innovation #DigitalHealth #SecureDataAccess #BioTechXEU #Biotechnology #PopulationGenomics #Lifebit
-
NEWS ANNOUNCEMENT! We’re excited to expand our partnership with Flatiron Health into Japan, empowering researchers with secure access to high-quality oncology real-world data (RWD) through our Trusted Research Environment (TRE) 🚀🔒 Using Flatiron’s RWD and Lifebit’s TRE technology, researchers are safely analyzing data without moving it—ensuring privacy and compliance for these highly sensitive data. Flatiron Health will be presenting findings from novel research powered by Lifebit’s TRE on early-onset gastric and colorectal cancer in Japan and the U.S. next week at the Asian Conference on Pharmacoepidemiology ACPE. Dr. Maria C. Dunford, CEO of Lifebit, says: "Our federated Trusted Research Environment allows for unparalleled access to valuable real-world cancer data, with the highest level of data security and privacy. We are excited to see the outcomes of this partnership, particularly in how it will contribute to improving cancer care and outcomes for patients worldwide." Read more in our press release https://bit.ly/3XYZNjt #CancerResearch #DataSecurity #RWD #TrustedResearchEnvironment #Oncology #PrecisionMedicine #HealthcareInnovation #FlatironHealth #Lifebit #RWD
-
🚀 We are thrilled to announce that Lifebit is now available on AWS Marketplace! 🚀 Our federated data solutions are empowering healthcare, pharma, and research organizations to securely leverage distributed datasets across borders—accelerating biomedical innovation without moving sensitive data. 🧬 With AWS’s scalable infrastructure, Lifebit delivers high-performance computing, secure data access, and AI-powered insights to drive precision medicine forward. 🕵️ Explore more about our Federated Platform and Trusted Research Environment on our AWS Marketplace listing: https://lnkd.in/drnnde-c 🗞️ Read more in our press announcement: https://bit.ly/4gKFMpL #AWSMarketplace #PrecisionMedicine #FederatedData #LifeSciences #HealthcareInnovation #DigitalTransformation
-
Congratulations to the whole team at Genomics England for the huge milestone, announced today, in this important national healthcare initiative. Newborn genomic screening programmes around the world have demonstrated the ability to detect early onset, actionable genetic conditions at birth, enabling earlier diagnosis and treatments that could help slow the progression of rare conditions and even extend lives. #genomics #raredisease #DNA #genomicsequencing
The Generation Study is a ground-breaking research study in partnership with the NHS which will sequence the whole genomes of up to 100,000 newborn babies and look for 200+ rare conditions in early childhood. Find out more via this link: https://ow.ly/ZPVi50TBVQq
-
One week to go! Team Lifebit is getting ready to travel to Basel, Switzerland for next week’s #BiotechXEurope event, where we’re looking forward to connecting with innovators and experts in genomics and biopharma. What’s on offer? 📍VISIT us at Stand 736 to meet our team of data experts and find out how you can be part of our 🌍 global data network. 🌟 LEARN how our unique federated data platform is enabling secure data access and analysis, fuelling breakthroughs in genomics and health research ☕ FREE COFFEE - grab a freshly brewed coffee from our barista! 📅 JOIN our Population Genomics session on 9th October, chaired by Thorben Seeger and featuring our CEO Maria Dunford, who will tackle population genomics challenges for pharma. 🤝 CONNECT with our team Dr. Maria C. Dunford, Thorben Seeger, Roubini Tsakri, Karl Quinn, Hamzah Syed, Christina Chatzipantsiou, Michael Lawton We look forward to seeing you there! 👋 #PopulationGenomics #SecureDataAccess #DigitalHealth #Pharma #DataScience #GenomicsInnovation #BiotechX #HealthcareInnovation